Efficacy and Safety of Apixaban in the Treatment of Heparin Induced Thrombocytopenia (HIT)
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
Conditions: Heparin-induced Thrombocytopenia
Age: Between 18 - 80 Years
Gender: Male or Female
Contact the research team to learn more about this study.
Fields marked with asterisk (*) are required